VANCOUVER, British Columbia--(BUSINESS WIRE)--Dec. 5, 2005--ProtoKinetix, Inc.'s (OTCBB:PKTX) president and CEO, Dr. John Todd, is pleased to announce that Cabinet Moutard, the prestigious patent specialists in France, have completed filing the AAGP(TM) patents. This extremely detailed filing is a world wide patent of the anti-aging glycoprotein family of molecules. The patents include all practical derivatives, variations and extensions of the AAGP(TM) molecule plus all applications.